← All Sanuwave Health, INC filings

Sanuwave Health, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
SNWV
Sanuwave Health, INC
10-K: SANUWAVE Health Reports Strong 2025 Growth, Net Income Turnaround
SANUWAVE Health, Inc. announced a significant financial turnaround in its 2025 annual report, achieving net income and substantial revenue growth following a debt refinancing and prior period restatements.
NASDAQ
SNWV
Sanuwave Health, INC
10-K: SANUWAVE Health Reports Strong Revenue Growth in 2024, But Losses Persist Due to Derivative Valuations
SANUWAVE Health achieved a 60% increase in revenue for 2024, driven by UltraMIST sales, but net losses continued due to changes in derivative valuations and debt related costs.
NASDAQ
SNWV
Sanuwave Health, INC
10-K: SANUWAVE Health, Inc. Reports 22% Revenue Growth in 2023, Eyes Merger Completion
SANUWAVE Health, Inc. saw a 22% increase in revenue in 2023 and is working towards completing a merger with SEP Acquisition Corp.